Facebook
Twitter
Telegram
Report an ErrorIntellia Therapeutics Cash Flow 2011-2024 | NTLA
Annual Cash Flow Intellia Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-394 M | -333 M | -225 M | -49.9 M | -103 M | -61.3 M | -65.3 M | 36.1 M | - | - | - | - | - |
Depreciation & Amortization |
8.98 M | 7.57 M | 6.89 M | 6.31 M | 5.59 M | 4.46 M | 2.99 M | 1.1 M | 328 K | - | - | - | - |
Accounts Payables |
7.45 M | 5.15 M | 9.65 M | 10.5 M | 3.94 M | 2.71 M | 2.17 M | 4.65 M | - | - | - | - | - |
Accounts Receivables |
36.5 M | 3.77 M | 2.03 M | 2.13 M | 4.62 M | 7.55 M | 10.5 M | 6.45 M | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Intellia Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-121 M | - | - | - | -109 M | - | -243 M | - | -79.8 M | - | -170 M | - | -52.4 M | - | -9.69 M | 18.9 M | -38.5 M | - | -74.6 M | -49.1 M | -21.5 M | - | -52.7 M | -40.3 M | -17.8 M | - | -44 M | -27.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
2.51 M | - | - | - | 2.05 M | - | 5.54 M | - | 1.75 M | - | 5.01 M | - | 1.59 M | - | 4.71 M | 3.11 M | 1.54 M | - | 4.02 M | 2.64 M | 1.3 M | - | 3.24 M | 2.08 M | 1.01 M | - | 2.16 M | 1.37 M | 660 K | - | 699 K | 434 K | 187 K | - | 196 K | 100 K | 33 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
13.7 M | 7.45 M | 3.55 M | 11.6 M | 6.89 M | 5.15 M | 4.38 M | - | 10.1 M | 9.65 M | 7.47 M | 6.85 M | 8.69 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 3.94 M | 3.94 M | 3.94 M | 3.94 M | 2.71 M | 2.71 M | 2.71 M | 2.71 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | 4.65 M | 4.65 M | 4.65 M | 4.65 M | 1.36 M | 1.36 M | 1.36 M | 1.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
36.4 M | 36.5 M | 6.49 M | 5.06 M | 4.91 M | 3.77 M | 4.02 M | 2.85 M | 1.8 M | 2.03 M | 2.49 M | 1.99 M | 953 K | 2.13 M | 2.13 M | 2.13 M | 2.13 M | 4.62 M | 4.62 M | 4.62 M | 4.62 M | 7.55 M | 7.55 M | 7.55 M | 7.55 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 6.45 M | 6.45 M | 6.45 M | 6.45 M | 1 M | 1 M | 1 M | 1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency